Table of contents and introductory materials for Vol. 43, no. 4, Fall 2016

ConnCensus Vol. 43 No. 9

CNS Drug Reviews, Vol. 4, No. 3, Fall 1998

Ipidacrine (NIK-247, 9-amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinoline monohydrochloride monohydrate) is a novel substance synthesized by the National Research Center for Biologically Active Compounds in the Russian Federation. Ipidacrine was earlier referred to by the chemical name amiridine (7). This compound contains the structure of 4-aminopyridine and is structurally very similar to ...

CNS Drug Reviews, Vol. 4, No. 3, Fall 1998

The recent approvals of Betaseron, Avonex, and Copaxone have improved treatment options for multiple sclerosis (MS), but these therapeutics delay the progression of disease in only ~30% of the patient population. There remains an unmet need for MS therapeutics, and several new drugs enter clinical testing each year in an attempt to meet this need (37,38). This review summarizes the development ...

CNS Drug Reviews, Vol. 4, No. 3, Fall 1998

This symposium was organized by P. Illes (Univ. Leipzig, Germany), A. Reichenbach (Paul-Flechsig Institute for Brain Research, Leipzig, Germany) and H. Zimmermann (Univ. Frankfurt/Main, Germany). More than 150 experts on purinergic transmission met at a historical building of the University of Leipzig in the center of the town. The symposium consisted of 32 twenty-minute-long lectures by invite...

CNS Drug Reviews, Vol. 4, No. 3, Fall 1998

The 21st annual meeting of the Canadian College of Neuropsychopharmacology (CCNP) was marked by participation of an unprecedented number of registrants > 200, comprising psychiatrists, pharmacologists, and neuroscientists from Canada and the U.S.A. The presentations consisted of four plenary lectures, three award lectures, eight symposia, and 97 posters. The major themes in the meeting included...